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Abstract
A profile-based search of the SWISS-PROT database reveals that most protein tyrosine phosphatases (PTPs) contain at least one
caveolin-1-binding motif. To ascertain if the presence of caveolin-binding motif(s) in PTPs corresponds to their actual localization in
caveolin-1-enriched membrane fractions, we performed subcellular fractionating experiments. We found that all tested PTPs
(PTP1B, PTP1C, SHPTP2, PTEN, and LAR) are actually localized in caveolin-enriched membrane fractions, despite their distri-
bution in other subcellular sites, too. More than 1/2 of LAR and about 1/4 of SHPTP2 and PTP-1C are localized in caveolin-
enriched membrane fractions whereas, in these fractions, PTP-1B and PTEN are poorly concentrated. Co-immunoprecipitation
experiments with antibodies specific for each tested PTP demonstrated that all five phosphatases form molecular complexes with
caveolin-1 in vivo. Collectively, our findings propose that particular PTPs could perform some of their cellular actions or are
regulated by recruitment into caveolin-enriched membrane fractions.  2002 Elsevier Science (USA). All rights reserved.
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Protein tyrosine phosphorylation is a key mechanism
for eukaryotic cell regulation, because it is involved in
several important processes such as cellular metabolism,
proliferation, differentiation, and oncogenic transfor-
mation [1]. In the cell, protein tyrosine phosphorylation
levels are balanced by the counteraction of protein ty-
rosine kinases (PTKs) and protein tyrosine phosphata-
ses (PTPs). The PTK family consists of receptor and
non-receptor enzymes: the former localized in the plas-
ma membrane, and the latter in other cell compart-
ments. The PTP super-family consists of four main
families: the tyrosine-specific phosphatases, the VH1-
like dual specificity phosphatases, the cdc25 phospha-
tases, and the low molecular weight phosphatases
(LMW-PTPs). Despite their extremely limited sequence
similarity, all share an active site motif consisting of a
cysteine and an arginine separated by five residues
(CXXXXXR, where C and R are essential residues and
X is any amino acid). All PTPs have an identical cata-
lytic mechanism, which involves the formation of a
cysteinyl-phosphate covalent intermediate [2].
Although receptor PTKs were considered to be the
principal enzymes regulating mitogenic protein phos-
phorylation cascades, the presence of Src homology-2
(SH2) domains in specific PTPs and the receptor-like
structure of some membrane PTPs clearly indicate that
PTPs too are regulated in the cell. Furthermore, a
number of recent reports indicate additional regulation
mechanisms for PTPs, such as the action of NO and
other reactive oxygen species (ROS) on the active site
cysteine, which determine the transient inactivation of
these enzymes [3–8].
Caveolae are flask-shaped plasma membrane invag-
inations with characteristic diameter in the 50–100mm
range [9,10]. Though caveolae are present in most cells,
they are particularly abundant in terminally differenti-
ated one such as the adipocytes, endothelial, and skeletal
muscle cells. Recent studies have revealed the presence
of at least three mammalian caveolin sub-types, caveo-
lin-1, caveolin-2, and caveolin-3, with different tissue
distribution ([11], and citations therein). The interaction
between caveolin-1 and other proteins is mediated by a
short stretch of the membrane-proximal region (or
caveolin-1 scaffolding domain), formed by residues 82–
101, which recognizes and binds proteins containing the
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sequence motif wXwXXXXw or wXXXXwXXw, where
w is an aromatic residue and X is any amino acid [12].
We carried out a search in the SWISSPROT data-
base, and found that at least one caveolin-1-binding
motif is contained in most PTPs. Furthermore, we
demonstrated that all five tested PTPs are in reality as-
sociated to the caveolin-enriched membrane fractions,
despite being localized in other cellular sites as well.
Since caveolae seem to regulate several signaling mole-
cules, our findings suggest that PTPs are also regulated
by association to caveolae during signaling.
Materials and methods
Materials. Polyclonal anti-SHPTP2 (sc-280) antibodies were from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies di-
rected against caveolin-1 (C13630, polyclonal), PTP1B (P-18020,
monoclonal), PTP1C (P17320, monoclonal), PTEN (P96520, mono-
clonal), LAR (L33420, monoclonal), and gelsolin were purchased from
Transduction Laboratories.
Protein determination. Protein concentration was assayed by the
bicinchoninic acid method (BCA-kit) purchased from Sigma.
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE). SDS–PAGE was performed according to Laemmli [13].
Cell culture.Human A431 cells were grown at 37 C in a humidified
atmosphere containing 5% CO2 in Dulbecco’s modified Eagle’s me-
dium (DMEM), supplemented with 10% foetal calf serum and anti-
biotics (penicillin, streptomycin).
Detergent-free purification of caveolin enriched membrane fractions.
Low-density caveolin-enriched membrane fractions were isolated as
described by Song et al. [14]. Briefly, one confluent 100-mm dish,
washed twice with ice-cold phosphate-buffered saline (PBS: 10mM
sodium phosphate and 0.15M NaCl, pH 7.2), was scraped into 0.5ml
of sodium carbonate buffer (500mM sodium carbonate, pH 11, 25mM
4-morpholineethanesulfonic acid, 150mM NaCl, and 1mM phen-
ylmethanesulfonyl fluoride, 1lg/ml leupeptin, 1lg/ml aprotinin). Cells
were homogenized extensively using a Dounce homogenizer (50
strokes). The homogenate was then adjusted to 45% sucrose by the
addition of 0.65ml of 80% sucrose in 25mM (morpholinoethane
sulfonic acid (MES), 150mM NaCl, and 1mM phenylmethanesulfonyl
fluoride, 1lg/ml leupeptin, 1 lg/ml aprotinin, and then placed at the
bottom of an ultracentrifuge tube. A 5–35% discontinuous sucrose
gradient was formed above the 45% layer, by adding 2.5ml of 35%
sucrose and 1.3ml of 5% sucrose, both in 250mM sodium carbonate,
pH 11, 25mMMES, 150mMNaCl, and 1mM phenylmethanesulfonyl
fluoride, 1lg/ml leupeptin, 1lg/ml aprotinin. The gradient was cen-
trifuged at 170,000g for 20 h using a Beckman SW50.1 rotor. For the
analysis of the resulting gradient, 0.35ml fractions were collected from
the top to the bottom of the gradient. The insoluble pellet (fraction 15)
was dissolved into 50 ll of Laemmli sample buffer. The proteins con-
tained in the fractions were separated by SDS–PAGE, and transferred
onto a polyvinylidene difluoride membrane. Blots were probed first
with specific antibodies, and then with secondary antibodies conju-
gated with horseradish peroxidase, washed, and developed with the
enhanced chemiluminescence kit.
Immunoprecipitation experiments. Cells were cultured in 100mm
dishes were washed with PBS, lysed in ice-cold lysis buffer (50mM
Tris, pH 7.5, 150mM NaCl, 1% Triton X-100, 60mM n-octylgluco-
side, 2mM EDTA, 1mM orthovanadate, 100mM NaF, 1mM phen-
ylmethanesulfonyl fluoride, 1lg/ml leupeptin, 1 lg/ml aprotinin) and
insoluble material was removed by centrifugation at 10,000g for
10min. For immunoprecipitation, protein concentration of the lysate
was adjusted to 1mg/ml by diluting with the lysis buffer, and 1mg total
protein was used in each experiment. Then specific anti-PTP antibodies
ð1lgÞ were added, and the mixtures were incubated overnight at 4 C.
After 1-h incubation with protein A–Sepharose beads at 4 C, the
immunocomplexes were collected and washed extensively (three times)
with lysis buffer. The beads were suspended in 20 ll of two-fold con-
centrated Laemmli electrophoresis buffer (without 2-mercap-
toethanol), separated by SDS–PAGE and electroblotted onto
polyvinylidene difluoride membranes for detection.
Results
Most eukaryotic PTPs contain one or more potential
caveolin-1-binding motifs
A profile-based search of the SWISS-PROT database,
Eukaryota section, using the program PATTINPROT at
PBIL (Po^le Bio-Informatique Lyonnais), revealed that
most of known eukaryotic PTPs and dual specificity
protein phosphatases contain one or both the caveolin-1-
binding motifs ðwXwXXXXw or wXXXXwXXw) de-
scribed by Couet et al. [12]. This finding implies that some
PTPs are potentially recruited into caveolae, and suggests
that some of them elicit a part of their cellular functions or
are regulated within these lipid raft membrane domains.
To investigate the possible localization into caveolin-
enriched membrane fractions of the PTPs containing
putative caveolin-1-binding domains, we have selected
five human PTPs: PTP1B, PTP1C, SHPTP2, PTEN, and
LAR, taking into account that A431 cells were known to
express these PTPs. Table 1 shows the potential caveolin-
1-binding motifs contained in the above PTPs.
Some PTPs associate with caveolin-enriched membrane
domains in vivo, and coimmunoprecipitate with caveolin-1
We lysed near-confluent human A431 cells and then
separated the caveolae-enriched membrane domains
from other cellular components, using the density gra-
dient centrifugation method described in Materials and
methods. Fifteen fractions were collected from the top
of the gradient. A constant volume from each fraction
was analyzed by SDS–PAGE and Western blotting with
anti-caveolin-1 antibody. All the results shown in Fig. 1
demonstrate that the caveolin-1 band is essentially re-
stricted to fractions 5–7 indicating the position of the
caveolin-enriched membrane domains in the gradient.
To ascertain the fractions containing the various PTPs
(PTP1B, PTP1C, SHPTP2, PTEN, and LAR), we per-
formed Western blot analysis with specific antibodies
directed against each PTP. In all cases both the caveolin-
enriched membrane domains (fractions 5–7) and the
bulk cell fractions (fractions 9–15) contained the above
PTPs, although their relative abundance is different. Fig.
3 summarizes the data obtained by densitometry: greater
than 60% of total LAR is localized in caveolin-enriched
membrane fractions that contain, however, only about
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10% of PTP1B and PTEN. Furthermore, about 30% of
total PTP-1C and SHPTP2 are localized in caveolin-
enriched membrane domains of A431 cells. The result of
a control experiment performed with gelsolin (a cyto-
solic actin-binding protein) confirms its extra-caveolar
localization (Figs. 1 and 3). Additionally, we found that
more than 99% of total cellular proteins were excluded
from the caveolin-rich membrane fractions (data not
shown).
To determine whether each PTP (PTP1B, PTP1C,
SHPTP2, PTEN, and LAR) interacts directly with
caveolin-1 in vivo, we performed co-immunoprecipita-
tion experiments human A431 cell lysate. Immune-
complexes were collected on protein A–Sepharose,
separated by SDS–PAGE, and immunoblotted using
antibodies specific for caveolin-1 as well as those specific
for each PTP. The results shown in Fig. 2 demonstrate
that all tested PTPs co-immunoprecipitate with caveo-
lin-1, thus indicating that they are complexed in vivo
with caveolin-1 in human A431 cells. In contrast, the
immunoprecipitate obtained with antibodies directed
against gelsolin (a cytosolic actin-binding protein) does
not contain caveolin-1 (Fig. 2).
Discussion
Protein phoshorylation on specific tyrosine residues is
the main mechanism that controls important cellular
processes such as cell growth, proliferation, locomotion,
Table 1
Caveolin-1-binding motifs
Accession No. PTP Position Motif
O00633 PTEN Homo sapiens 271–278 FHFWVNTF
P29350 PTP-1C H. sapiens 206–213 FVYLRQPY
Q06124 SH-PTP2 H. sapiens 416–423 WQYHFRTW
P10586 LAR (precursor) H. sapiens 531–538 IMYELVYW
1355–1362 FTWENSNL
P18031 PTP-1B H. sapiens 174–182 FHYTTWPDF
P10586 LAR (precursor) H. sapiens 1785–1793 IRQFQFTDW
Fig. 1. In human A431 cells, PTP1B, PTP1C, SHPTP2, PTEN, and LAR in part co-fractionate with caveolin-enriched membrane domains and in
part with other cellular fractions. Cells were subjected to sub-cellular fractionation on a discontinuous sucrose density gradient after homogenization
in alkaline buffer at the conditions described in Materials and methods. Sucrose gradients were fractionated by collecting 0.35ml fractions from the
top, and 30 ll of each fraction were subjected to immunoblot analysis with specific antibodies directed against caveolin-1, PTP1B, PTP1C, SHPTP2,
PTEN, and LAR. Note that caveolin-enriched membrane domains (fractions 5–7) are separated from gelsolin (fractions 11–15). One representative
experiment for each PTP is shown (n ¼ 3).
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differentiation, transformation, and metabolism. Two
kinds of enzymes (PTKs and PTPs) are involved in
balancing the tyrosine phosphorylation level of cellular
proteins. Until recently, most studies were focused on
the regulation of the activity of PTKs, because PTPs
were initially believed to be few in number and to have
little substrate specificity; furthermore, they were
thought to exert a mere ‘‘housekeeping’’ role [15]. On
the contrary, PTPs form a large family subjected to
sophisticated modes of regulation, and playing critical
role in controlling a wide range of signaling pathways
[15]. In addition, recent findings indicate certain PTPs to
be highly specific, not only for a particular protein
substrate but also for specific phosphorylation sites
([15], and citations therein). In some cases their speci-
ficity is conferred by intracellular targeting, but there are
also examples in which PTP catalytic domains display
high specificity on the recognition of substrates. Tonks
and Nee [15] have suggested that PTP specificity is ac-
tually governed by targeting and catalytic domains
acting in a combinatorial fashion.
This study offers evidence that most PTPs contain
one or more potential caveolin-1 binding-sequence-mo-
tifs, which are generally thought to be involved in tar-
geting proteins to the caveolae rafts. Caveolin-enriched
membrane fractions are rich in cholesterol, glyco-
sphingolipids, and sphingomyelin. Caveolin-1, a
22–24 kDa protein, is a major integral membrane com-
ponent of caveolae. Caveolin-1 is ubiquitous and is in-
volved not only in the recruitment of protein to
caveolae, but also in regulating the activities of several
signaling molecules such as etherotrimeric G-proteins,
Src kinases, nitric oxide synthase, epidermal growth
factor, and platelet-derived growth factor receptors, as
well as of protein kinase C. All these signaling molecules
contain at least one of the sequence signature motifs
described above. Binding of these proteins with caveo-
lin-1 may produce negative or positive regulation of
their activity ([10], and citations therein).
Fig. 2. In human A431 cells, PTP1B, PTP1C, SHPTP2, PTEN, and LAR co-immunoprecipitate with caveolin-1. PTPs were immunoprecipitated
from the human A431 cell lysate in separate experiments using specific antibodies directed against each particular PTPs. The immunoprecipitates
were collected by the addition of protein A–Sepharose beads and analysed by SDS–PAGE. Caveolin-1 was immunodetected by the anti-caveolin-1
antibody, whereas the various PTPs were immunodetected by a set of antibodies, each directed against a particular PTP. One representative
experiment for each PTP is shown (n ¼ 3).
Fig. 3. Densitomentric analysis of PTP1B, PTP1C, SHPTP2, PTEN,
LAR, and gelsolin contained in caveolae-enriched membrane domains
and in bulk cellular fractions. Densitometric analysis was performed
on the images reported in Fig. 1, using the Quantity One software
(BioRad).
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Caveolin-1 is phosphorylated on tyrosine-14 by
the oncogenic viral Src kinase, and is associated with
normal cellular Src and other Src family tyrosine kinases
[16,17]. The functional consequences of tyrosine phos-
phorylation of caveolin-1 are not well understood,
although several reports suggest some involvement of
caveolin phosphorylation in several cellular processes
[18–25].
To assess whether the presence of caveolin-binding
motifs in PTPs actually determines their association
with caveolin-1 and their recruitment into caveolin-
enriched membrane domains, we have selected five PTPs
(PTP1B, PTP1C, SHPTP2, PTEN, and LAR), all
expressed in human A431 cells, and performed two
kinds of experiments: (i) sucrose gradient centrifugation
to test their eventual localization into caveolin-enriched
membrane fractions, and (ii) immunoprecipitation of
caveolin-1–PTP complexes using antibodies specific to
each PTP. Four out of the five PTPs (PTP1B, PTP1C,
SHPTP2, and PTEN) contain one canonical caveolin-1-
binding motifs, whereas human LAR contains three
similar motifs (see Table 1). In their study on caveolin-
1-binding motifs Couet et al. [12] reported that almost
10% of the selected 15-mer peptides in their library
contained only two aromatic residues. They also
reported that Gaq contained valine and leucine as
substitutes for aromatic residues and that it nevertheless
coimmunoprecipitates with caveolin-1. Furthermore,
Carman et al. [26] reported that all known G-protein-
coupled receptor kinases contained the conserved
caveolin-1-binding motif I/LXXXXFXXF.
The results reported in Fig. 1 show that all tested
PTPs are localized in part in caveolin-enriched mem-
brane domains and in part in other cellular fractions.
Furthermore, the co-immunoprecipitation results shown
in Fig. 2 demonstrate that in A431 cell caveolin-1 is able
to form molecular complexes with all the tested PTPs.
Taken together our findings reveal that the potential
caveolin-1-binding motifs contained in the five PTPs
expressed in A431 cells are indeed involved in binding
with caveolin-1, which may determine the recruitment of
these PTPs into caveolin-enriched membrane domains.
Previous findings have demonstrated that the two
other PTPs were localized in caveolin-enriched mem-
brane domains: CD45 [27] and LMW-PTP [28]. CD45 is
a receptorial PTP involved in both T- and B-cell sig-
naling, whereas LMW-PTP is a small enzyme involved
in down-regulating PDGF and insulin receptors and in
regulating citoskeleton rearrangement. CD45 contains
one canonical caveolin binding motif ðwXwXXXXw),
whereas LMW-PTP, which is able to associate with
caveolin-1 in vivo [28], contains a caveolin-1-binding
motif identical to that found in the G-protein coupled
receptor kinases [26].
First Liu and co-workers [29] reported that multiple
caveolae proteins acquire phosphotyrosine when PDGF
binds to its receptor. Successively, other authors de-
scribed that other caveolae-recruited proteins (such as
endothelial nitric oxide synthase, epidermal growth
factor, STAT3, the low-density lipoprotein receptor-re-
lated protein, and dynamin [30–35]) are phosphorylated
during normal or pathological signaling. Collectively,
these reports demonstrate the presence of several tyro-
sine phosphorylated proteins in the caveolae rafts; their
phosphorylation may cause changes in their cellular
localization or activity [30,32,35]. In some cases, the
protein tyrosine kinases phosphorylating caveolae pro-
teins are known, but only one report indicates a
caveolae target substrate for a particular PTP, the
LMW-PTP [28]. It is well known that a large number of
genes codify for PTPs, but the cellular targets for each
PTP are generally unknown. The presence of multiple
protein substrates phosphorylated on tyrosine into
caveolae suggests that their phosphorylation state is
regulated not only by the action of protein tyrosine
kinases, but also by certain PTP family members able to
be recruited into caveolae. Our results demonstrate that
most PTPs contain potential caveolin-binding motifs
probably involved in their recruitment into caveolin-
enriched membrane fractions. We put forward the idea
that some PTPs play a part of their cellular actions on
caveolar protein substrates.
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